Marie C. Le Deley

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee.

Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee.

Journal: Cancer medicine

Published: August 21, 2024

Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?

Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?

Journal: Cancers

Published: February 09, 2023

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

Journal: Current oncology (Toronto, Ont.)

Published: December 12, 2022

Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer.

Prognostic impact of tumor size reduction assessed by magnetic resonance imaging after radiochemotherapy in patients with locally advanced cervical cancer.

Journal: Frontiers in oncology

Published: September 16, 2022

Expertise for management of immune-related adverse events in cancer therapy: Mapping of French practicing

Expertise for management of immune-related adverse events in cancer therapy: Mapping of French practicing

Journal: Bulletin du cancer

Published: April 05, 2022

DEPOSEIN-how meaningful was the benefit from intrathecal chemotherapy?

DEPOSEIN-how meaningful was the benefit from intrathecal chemotherapy?

Journal: Neuro-oncology

Published: August 19, 2020

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.

Journal: Neuro-oncology

Published: October 23, 2019

A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.

A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.

Journal: Journal of clinical pharmacology

Published: January 23, 2018

Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.

Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.

Journal: Pediatric blood & cancer

Published: February 22, 2016

The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB

The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB

Journal: Bulletin du cancer

Published: September 22, 2014

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Journal: Cancer discovery

Published: September 17, 2014

Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.

Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 10, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026